JFS Wealth Advisors’s Maravai LifeSciences MRVI Stock Holding History

JFS Wealth Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$42	–	1973
2024 Q3	$42	Hold	5	–	–	﹤0.01%	1936
2024 Q2	$36	Hold	5	–	–	﹤0.01%	1969
2024 Q1	$44	Hold	5	–	–	﹤0.01%	1982
2023 Q4	$33	Sell	5 -1	-17%	-$6	﹤0.01%	1986
2023 Q3	$60	Sell	6 -2	-25%	-$22	﹤0.01%	1927
2023 Q2	$100	Sell	8 -1	-11%	-$13	﹤0.01%	1925
2023 Q1	$127	Buy	9 +5	+125%	+$72	﹤0.01%	1874
2022 Q4	$57	Buy	+4	New	+$63	﹤0.01%	1916

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JFS Wealth Advisors's MRVI Position: Q4 2024 in Review

JFS Wealth Advisors sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 5 shares — an estimated $42 sold.

JFS Wealth Advisors first reported a position in MRVI in Q4 2022 and held it in 8 quarters. The position peaked at $127 in Q1 2023. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

JFS Wealth Advisors reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
JFS Wealth Advisors sold 5 Maravai LifeSciences shares in Q4 2024, an estimated $42.
JFS Wealth Advisors first reported a position in Maravai LifeSciences in Q4 2022 and held it in 8 quarters.
JFS Wealth Advisors's Maravai LifeSciences position peaked at $127 in Q1 2023.
185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on JFS Wealth Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.